Brought to you by 
Cambridge Genetics acquires Cambridge Drug Discovery
22 Nov 2000
Executive Summary
Cambridge Genetics (retroviral display platform for target validation and discovery, drug discovery, and gene therapy) has paid about $1mm in cash to acquire small-molecule drug discovery firm Cambridge Drug Discovery, forming a new company called Cambridge Drug Discovery Holdings Ltd., also focusing on the discovery of small-molecule therapeutics.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cambridge Genetics acquires Cambridge Drug Discovery
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice